Safety of 96-hour incision-site continuous infusion of ropivacaine for postoperative analgesia after bowel cancer resection

Therapeutic Drug Monitoring

Volumn 29, Issue 1, 2007, Pages 57-63

  Corso, Olivia H ^a,b   Morris, Raymond G ^a,b   Hewett, Peter J ^a   Karatassas, Alex ^a  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Local anesthetic; Postoperative pain; Ropivacaine

Indexed keywords

FENTANYL; OROSOMUCOID; ROPIVACAINE;

AGED; ARTICLE; BLOOD SAMPLING; CANCER SURGERY; CLINICAL ARTICLE; CONTINUOUS INFUSION; DRUG SAFETY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INCISION; INFUSION PUMP; INTESTINE CANCER; LOADING DRUG DOSE; MALE; PATIENT CONTROLLED ANALGESIA; POSTOPERATIVE ANALGESIA; POSTOPERATIVE PAIN; PRIORITY JOURNAL; PROTEIN BINDING; VISUAL ANALOG SCALE;

AGED; AGED, 80 AND OVER; AMIDES; ANALGESIA, PATIENT-CONTROLLED; ANESTHETICS, LOCAL; AUSTRALIA; CICATRIX; COLECTOMY; COLONIC NEOPLASMS; DRUG MONITORING; FEMALE; FENTANYL; HUMANS; INFUSIONS, PARENTERAL; LENGTH OF STAY; MALE; MORPHINE; OROSOMUCOID; PAIN, POSTOPERATIVE; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; TIME FACTORS; TREATMENT OUTCOME;

EID: 33847149767     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/FTD.0b013e31802c59ec     Document Type: Article

References (23)

1. Bianconi M, Ferraro L, Traina GC, et al. Pharmacokinetics and efficacy of ropivacaine continuous wound instillation after joint replacement surgery. Br J Anaesth. 2003;91:830-835.
2. Karatassas A, Morris RG, Slavotinek AH. The relationship between blood flow and absorption of lignocaine. Aust N Z J Surg. 1993;63:766-771.
3. Morris RG, Karatassas A, Orfanos A. Regional blood flowas a determinant of drug pharmacokinetics - description of an animal model. J Pharmacol Toxicol Methods. 1993;30:39-45.
4. Burm AG, Stienstra R, Brouwer RP, et al. Epidural infusion of ropivacaine for postoperative analgesia after major orthopedic surgery: pharmacokinetic evaluation. Anesthesiology. 2000;93:395-403.
5. Erichsen CJ, Sjovall J, Kehlet H, et al. Pharmacokinetics and analgesic effect of ropivacaine during continuous epidural infusion for postoperative pain relief. Anesthesiology. 1996;84:834-842.
6. Lee A, Fagan D, Lamont M, et al. Disposition kinetics of ropivacaine in humans. Anesth Analg. 1989;69:736-738.
7. Wulf H, Worthmann F, Behnke H, et al. Pharmacokinetics and pharmacodynamics of ropivacaine 2 mg/mL, 5 mg/mL, or 7.5 mg/mL after ilioinguinal blockade for inguinal hernia repair in adults. Anesth Analg. 1999;89:1471-1474.
8. Knudsen K, Beckman Suurkula M, Blomberg S, et al. Central nervous and cardiovascular effects of i.v. infusions of ropivacaine, bupivacaine and placebo in volunteers. Br J Anaesth. 1997;78:507-514.
9. Scott DB, Lee A, Fagan D, et al. Acute toxicity of ropivacaine compared with that of bupivacaine. Anesth Analg. 1989;69:563-569.
10. Cheong WK, Seow-Choen F, Eu KW, et al. Randomized clinical trial of local bupivacaine perfusion versus parenteral morphine infusion for pain relief after laparotomy. Br J Surg. 2001;88:357-359.
11. Dowling R, Thielmeier K, Ghaly A, et al. Improved pain control after cardiac surgery: results of a randomized, double-blind, clinical trial. J Thorac Cardiovasc Surg. 2003;126:1271-1278.
12. Ekatodramis G, Borgeat A, Huledal G, et al. Continuous interscalene analgesia with ropivacaine 2 mg/ml after major shoulder surgery. Anesthesiology. 2003;98:143-150.
13. Kampe S, Warm M, Kasper SM, et al. Concept for postoperative analgesia after pedicled TRAM flaps: continuous wound instillation with 0.2% ropivacaine via multilumen catheters. A report of two cases. Br J Plast Surg. 2003;56:478-483.
14. Anonymous. American Society of Anesthesiologists. New classification of physical status. Anesthesiology. 1963;24:111.
15. Nation RL, Peng GW, Chiou WL. High-performance liquid chromatographic method for the simultaneous determination of lidocaine and its N-dealkylated metabolites in plasma. J Chromatogr. 1979;162:466-473.
16. Luzzi FA, Wenger TL, Klinger JK, et al. Simultaneous determination of lidocaine and its metabolites in plasma and myocardium. J Chromatogr. 1984;311:291-299.
17. Shah VP, Midha KK, Findlay JWA, et al. Bioanalytical method validation. A revisit with a decade of progress. Pharm Res. 2000;17:1551-1557.
18. Dickenson AH. Gate control theory stands the test of time. Br J Anaesth. 2002;88:755-757.
19. Melzack R, Wall PD. Pain mechanism: a new theory. Science. 1965;150:971-979.
20. Wiedemann D, Muhlnickel B, Staroske E, et al. Ropivacaine plasma concentrations during 120-hour epidural infusion. Br J Anaesth. 2000;85:830-835.
21. Saeden MR, Glass PSA. Pharmacokinetics in the elderly. Best Pract Res Clin Anaesthesiol. 2003;17:191-205.
22. Veering BT, Burm AGL, van-Kleef JW. Epidural anaesthesia with bupivacaine: effects of age on neural blockade and pharmacokinetics. Anesth Analg. 1987;66:589-593.
23. Veering B, Burm A, Vletter A. The effect of age on the systemic absorption and systemic disposition of bupivacaine after subarachnoid administration. Anesthesiology. 1991;74:250-257.